Linden develops relationships with the world’s leading healthcare and life science companies.
Linden’s sourcing strategy is aimed at creating proprietary or advantaged investment opportunities. To accomplish this objective, Linden uses three interlocking resources:
Corporate relationship management program
In-house market intelligence program
Relationships with industry executives
These efforts augment Linden’s traditional sourcing through investment banks, business brokers, attorneys and accountants.
A key component of Linden’s strategy is building long-term relationships with the largest healthcare and life
science companies in the world. Linden monitors the strategic activities of the largest 250 companies in the
healthcare and life science industry through Linden’s outbound
calling efforts. This monitoring drives
the initial identification of targets and enables the direct dialogue with corporations. Linden maintains direct
relationships with many of these companies and often has multiple contacts at various levels within a company. When
Linden does not have a strong relationship, the firm’s network of executives (Operating Partners and the Linden Resource
Network) often provides personal introductions to senior management at these corporations.
Through this corporate relationship management program, Linden proactively meets with senior executives to:
Create strategic alternatives for a parent corporation’s non-core operations while creating advantaged investment opportunities for Linden
Offer leads to independent businesses the corporate executives may know
Create flexible and innovative transaction structures that enable corporations to harvest more value from their maturing operations. Often, this takes the form of a continued minority ownership stake in the business.
